Cargando…

Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?

BACKGROUND AND AIM: Combined hepatocellular-cholangiocarcinoma (CHC) requires attention clinically and pathologically after liver transplantation (LT) because of its unique biology, difficulties in diagnosis, and being rare. We aimed to present our single-center experience for this incidental combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anilir, Ender, Oral, Alihan, Sahin, Tolga, Turker, Fatih, Yuzer, Yildiray, Tokat, Yaman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564256/ https://www.ncbi.nlm.nih.gov/pubmed/37822306 http://dx.doi.org/10.14744/hf.2022.2022.0037

Ejemplares similares

Factor 5 and Factor 2 heterozygous positivity and complications in living donor liver transplant donors
por: Anilir, Ender, et al.
Publicado: (2023)

Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
por: Sahin, Tolga, et al.
Publicado: (2020)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
por: Oral, Alihan, et al.
Publicado: (2019)

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study
por: Oral, Alihan, et al.
Publicado: (2019)

Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma
por: Oral, Alihan, et al.
Publicado: (2019)

Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Türker, Fatih, et al.
Publicado: (2021)

Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
por: Alim, Altan, et al.
Publicado: (2021)

Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
por: Türker, Fatih, et al.
Publicado: (2022)

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma
por: Bassullu, Nuray, et al.
Publicado: (2012)

Incarcerated Spigelian hernia: A rare cause of abdominal wall tender mass
por: Anilir, Ender, et al.
Publicado: (2019)

The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates
por: Koyuncu Sokmen, Bedriye, et al.
Publicado: (2021)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)

Does staged closure have a worse prognosis in gastroschisis?
por: Schmidt, Augusto Frederico, et al.
Publicado: (2011)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
por: Schwenk, Laura, et al.
Publicado: (2023)

Incidental Hepatocellular Carcinoma after Liver Transplantation: Clinicopathologic Features and Prognosis
por: Ozdemir, Fatih, et al.
Publicado: (2022)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Outcomes After Liver Transplantation With Incidental Cholangiocarcinoma
por: Safdar, Nawaz Z., et al.
Publicado: (2022)

Xanthoma striatum palmare
por: Oral, Alihan, et al.
Publicado: (2016)

Tacrolimus-induced gingival hyperplasia and recovery from tacrolimus to everolimus switching
por: Oral, Alihan, et al.
Publicado: (2019)

Factors Affecting Prognosis in the Course of Pediatric Celiac Disease
por: Taşkın, Didem, et al.
Publicado: (2022)

Incidental Finding of Riedel’s Lobe of the Liver and Intrahepatic Cholangiocarcinoma
por: Al-Handola, Rami, et al.
Publicado: (2023)

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)
por: Salvucci, Manuela, et al.
Publicado: (2022)

Comment on: Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients
por: Akbulut, Sami, et al.
Publicado: (2021)

Unclassified Diffuse Ductal Cholangiocarcinoma; Report of a Case
por: Aydın, Ünal, et al.
Publicado: (2014)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation
por: El Moghazy, Walid, et al.
Publicado: (2016)

Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2021)

Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma
por: Gerber, Tiemo Sven, et al.
Publicado: (2023)

IL-8 gene polymorphism in acute biliary and non biliary pancreatitis: probable cause of high level parameters?
por: Anilir, Ender, et al.
Publicado: (2017)

High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection
por: Titapun, Attapol, et al.
Publicado: (2021)

OPN and αvβ3 Expression are Predictors of Disease Severity and Worse Prognosis in Hepatocellular Carcinoma
por: Jin, Yi, et al.
Publicado: (2014)

Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data
por: Zeng, Zhili, et al.
Publicado: (2021)

Prognosis with Incidental Rolandic Spikes
por: Gertler, Tracy S., et al.
Publicado: (2015)

Incidental dural tears associated with worse clinical outcomes in patients operated for lumbar spinal stenosis
por: Alhaug, Ole Kristian, et al.
Publicado: (2022)

Mitral valve prolapse with ventricular arrhythmias: does it carries a worse prognosis?
por: Coutsoumbas, Gloria Vassilikì, et al.
Publicado: (2021)

Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma
por: Zhou, Yan-Ming, et al.
Publicado: (2017)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
por: Hou, Gui‐min, et al.
Publicado: (2021)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis
por: Adhoute, Xavier, et al.
Publicado: (2023)

Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma
por: Mantel, Hendrik T. J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_crr4jt8hnsis0rgsle81mptslt